Veridan Wealth LLC: DMXU position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Veridan Wealth LLC on DMXU, newest first. How the timeline and the estimate are built.
Veridan Wealth LLC held 6,571 DMXU shares at 2026-06-30 per its 13F-HR filed 2026-08-10.
the latest 13F is the newest step
- period ended2026-06-3013F 6,571 sharesChange vs previous 13F -17 shares
0.09% of the 13F portfolio, value $251,975.
13F-HR 0001951757-26-001205 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 6,588 sharesChange vs previous 13F -190 shares
0.09% of the 13F portfolio, value $231,516.
13F-HR 0001951757-26-000871 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 6,778 sharesChange vs previous 13F +132 shares
0.08% of the 13F portfolio, value $238,505.
13F-HR 0001951757-26-000451 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 6,646 sharesChange vs previous 13F +46 shares
0.08% of the 13F portfolio, value $230,266.
13F-HR 0001951757-25-001380 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 6,600 sharesChange vs previous 13F -2,585 shares
0.09% of the 13F portfolio, value $202,890.
13F-HR 0001951757-25-000411 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 9,185 sharesChange vs previous 13F not available
0.13% of the 13F portfolio, value $276,770.
13F-HR 0001951757-25-000185 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).